We are live on ! Find out more
PRCT icon

Procept Biorobotics

96 hedge funds and large institutions have $1.14B invested in Procept Biorobotics in 2022 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 33 increasing their positions, 13 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

780% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 5

154% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 13

66% more funds holding

Funds holding: 5896 (+38)

8.51% more ownership

Funds ownership: 70.42%78.93% (+8.5%)

5% more capital invested

Capital invested by funds: $1.08B → $1.14B (+$55.9M)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

44% less call options, than puts

Call options by funds: $2.72M | Put options by funds: $4.87M

Holders
96
Holders Change
+38
Holders Change %
+65.52%
% of All Funds
1.62%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
44
Increased
33
Reduced
13
Closed
5
Calls
$2.72M
Puts
$4.87M
Net Calls
-$2.15M
Net Calls Change
-$2.15M
Name Holding Trade Value Shares
Change
Change in
Stake
Carson Wealth (CWM LLC)
101
Carson Wealth (CWM LLC)
Nebraska
+$400 +11 New

PRCT Hedge Fund Activity: Q2 2022 in Review

96 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q2 2022, worth a combined $1.14B — up 5.2% from $1.08B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new PRCT positions and 5 closed out — a net gain of 39 holders — while 33 added to existing stakes and 13 trimmed.

The largest buyer was Vanguard Group, adding an estimated $67.2M. The largest seller was Viking Global Investors, cutting an estimated $76.9M.

  • 96 institutional investors held Procept Biorobotics (PRCT) as of Q2 2022, up from 58 in Q1 2022.
  • Funds reported $1.14B of Procept Biorobotics stock for Q2 2022, up 5.2% quarter-over-quarter.
  • 44 funds opened new Procept Biorobotics positions in Q2 2022 and 5 closed out, a net change of +39 holders.
  • The largest Procept Biorobotics buyer in Q2 2022 was Vanguard Group, an estimated $67.2M added.
  • The largest Procept Biorobotics seller in Q2 2022 was Viking Global Investors, an estimated $76.9M sold.

Based on aggregated 13F filings for Q2 2022.